{"title":"Brazil rejects Sputnik V vaccine, says it’s tainted with replicating cold virus","link":"https://arstechnica.com/?p=1761304","date":1619720289000,"content":"<div>\n<figure><img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232341031-800x567.jpeg\" /><p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232341031.jpeg\">Enlarge</a> <span>/</span> Vials of the Sputnik V vaccine against COVID-19 are seen at the Boris Trajkovski sports hall in Skopje as the country starts its vaccination campaign, after months of difficulties on April 16, 2021. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/vials-of-the-sputnik-v-vaccine-against-the-covid-19-are-news-photo/1232341031?adppopup=true\">Getty |  ROBERT ATANASOVSKI</a>)</p>  </figure><div><a name=\"page-1\"></a></div>\n<p>Health regulators in Brazil say that doses of Russia’s Sputnik V COVID-19 vaccine contain a cold-causing virus capable of replicating in human cells.</p>\n<p>The unintended presence of the virus in the vaccine can “lead to infections in humans and can cause damage and death, especially in people with low immunity and respiratory problems, among other health problems,” Brazil’s Health Regulatory Agency, Anvisa, said Wednesday in <a href=\"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2021/anvisa-nao-aprova-importacao-da-vacina-sputnik-v\">a translated statement</a>.</p>\n<p>Russia has unequivocally denied the claim, lobbed legal threats at Anvisa, and accused the respected regulators of being politically motivated to reject the vaccine.</p></div><p><a href=\"https://arstechnica.com/?p=1761304#p3\">Read 20 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1761304&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"cccb3592720b40cf04719731fd82d2d853cd02413b53e9f6392f9b17bff10feb","category":"Tech"}